Ads
related to: influenza c antibodies blood test
Search results
Results From The WOW.Com Content Network
A general procedure for HA is as follows, a serial dilution of virus is prepared across the rows in a U or V- bottom shaped 96-well microtiter plate. [5] The most concentrated sample in the first well is often diluted to be 1/5x of the stock, and subsequent wells are typically two-fold dilutions (1/10, 1/20, 1/40, etc.).
Influenza viruses are members of the family Orthomyxoviridae. [2] Influenza viruses A, B, C, and D represent the four antigenic types of influenza viruses. [3] Of the four antigenic types, influenza A virus is the most severe, influenza B virus is less severe but can still cause outbreaks, and influenza C virus is usually only associated with minor symptoms.
To do this, antibodies that are specific to different types of viruses are mixed with the tissue sample. After the tissue is exposed to a specific wavelength of light or a chemical that allows the antibody to be visualized. [citation needed] These tests require specialized antibodies that are produced and purchased from commercial companies.
In blood grouping, the patient's serum is tested against RBCs of known blood groups and also the patient's RBCs are tested against known serum types. In this way the patient's blood group is confirmed from both RBCs and serum. A direct Coombs test is also done on the patient's blood sample in case there are any confounding antibodies.
Consequently, those viruses bound to antibodies are unable to link RBCs, meaning that a test’s positive result due to hemagglutination has been inhibited. On the contrary, if hemagglutination occurs, the test will result negative. A schematic diagram of the experimental setup to detect hemagglutination for blood typing.
Examples are human antibodies F10, [31] FI6, [32] CR6261. They recognize sites in the stem/stalk region (orange region in figure at right), far away from the receptor binding site. [33] [34] In 2015 researchers designed an immunogen mimicking the HA stem, specifically the area where the antibody ties to the virus of the antibody CR9114.